Pfizer reports record revenue, expects Covid-19 vaccines to be commercialized later this year
[ad_1] In its 2022 fourth-quarter earnings call, company executives said that they expect sales of Covid-19 vaccines to decrease, in part because they still have shots that the government purchased last year to distribute. The decline in revenue also comes in part because an estimated 24 percent of the population will receive a Covid-19 vaccine…